Shawn Luetchens v. David Landau

CourtCourt of Chancery of Delaware
DecidedJune 30, 2026
DocketC.A. No. 2025-0359-KSJM
StatusPublished

This text of Shawn Luetchens v. David Landau (Shawn Luetchens v. David Landau) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shawn Luetchens v. David Landau, (Del. Ct. App. 2026).

Opinion

COURT OF CHANCERY OF THE STATE OF DELAWARE KATHALEEN ST. JUDE MCCORMICK LEONARD L. WILLIAMS JUSTICE CENTER CHANCELLOR 500 N. KING STREET, SUITE 11400 WILMINGTON, DELAWARE 19801-3734

Date Submitted: March 25, 2026 Date Decided: June 30, 2026

Alan R. Silverstein Brian E. Farnan Louis F. Masi Michael J. Farnan CONNOLLY GALLAGHER LLP FARNAN LLP 1201 N. Market St., 20th Floor 919 N. Market St., 12th Floor Wilmington, DE 19801 Wilmington, DE 19801

Re: Shawn Luetchens v. David Landau, et al., C.A. No. 2025-0359-KSJM

Dear Counsel:

The defendants have moved to dismiss the complaint under Court of Chancery

Rule 12(b)(6). The motion is granted in part.

Defendants David Landau and Ranjeet Bhatia (the “Individual Defendants”)

are the founders of Saffron Hill, a venture capital firm based in London. Plaintiff

Shawn Luetchens holds a 37.5% limited partnership interest in Defendant Saffron

Hill 2 Carry Limited Partnership (the “Carry LP”), a Delaware limited partnership.

The Carry LP holds a limited partnership interest in Defendant Saffron Hill Ventures

2 Limited Partnership (the “Operating LP”), also a Delaware limited partnership.

The Operating LP has invested in several startup companies.

Plaintiff Shawn Luetchens’s core claim is that he is entitled to a perpetual

“carry interest” in the investments of the Operating LP. Plaintiff seeks to enforce the

Individual Defendants’ alleged assurances “orally and in writing that his carried

interest would not be affected by any subsequent restructuring or reorganization” C.A. No. 2025-0359-KSJM Page 2 of 17 June 30, 2026

and further that “no action would be taken to reduce or impair Plaintiff’s carried

interest without Plaintiff’s express written consent.”1

But limited partnership agreements govern each of the limited partnerships.

And Plaintiff’s claim for breach of contract cannot be reconciled with those

agreements for a few reasons. Foremost, Plaintiff fails to identify a contract or a

contractual provision allegedly breached. Also, Plaintiff asserts breach of contract

claims against all six defendants, but he is a party to only one contract (the Carry LP

limited partnership agreement) and only one defendant (Saffron Hill 2 Carry GP

LLC, or the “Carry GP”) is a signatory to that contract. Plaintiff also asserts claims

against Saffron Hill Ventures 3 Limited Partnership (the “New Operating LP”), even

though he holds neither contractual relationship nor any interest, direct or indirect,

in that entity.

Plaintiff’s claim for breach of fiduciary duty, however, survives. Read

charitably, Plaintiff alleges that the Carry GP and Individual Defendants owed

Plaintiff fiduciary duties and breached those duties by restructuring Saffron Hill to

uniquely deprive Plaintiff of the value of his investment. Defendants mounted only

one full-throated defense to this claim—that it impermissibly duplicates the contract

claims at issue. This decision concludes otherwise. And given the fiduciary duty

claim survives, the unjust enrichment claim does as well.

1 C.A. No. 2025-0359-KSJM, Docket (“Dkt.”) 8 (“Am. Compl.”) ¶¶ 21, 24. C.A. No. 2025-0359-KSJM Page 3 of 17 June 30, 2026

I. FACTUAL BACKGROUND

The facts are drawn from the Verified Amended Complaint (the “Amended

Complaint”) and the documents it incorporates by reference.2

Saffron Hill is a venture capital firm. As restructured in 2007, the Operating

LP held interests in the portfolio companies, and the Carry LP held a limited

partnership interest in the Operating LP. The Carry GP is the general partner of the

Carry LP. Limited partnership agreements govern the Carry LP and the Operating

LP.3

Luetchens joined Saffron Hill in 2000 as a partner. At times, he worked as an

executive of different portfolio companies. Luetchens’s primary compensation was

“carry interest,” or the right to receive payment from the Carry LP based on

distributions (if any) from its limited partnership interest in the Operating LP.4

In late-2010, Plaintiff agreed to leave Saffron Hill. He remained on the boards

of several Saffron Hill portfolio companies with the expectation that he might return

2 Am. Compl. The Amended Complaint did not attach any of the parties’ agreements or communications that it references in numerous places. See, e.g., id. ¶ 2 (“Defendants’ effective cancellation of Plaintiff’s carried interest compensation violated express agreements[.]”), ¶ 40 (“Plaintiff’s unconditional partnership interest, and status as such, with Defendants has been repeatedly affirmed to Plaintiff in written and oral communications, as well as documents, delivered over the past 23 years.”). With their opening brief (“Defs.’ Opening Br.”), the defendants filed the Transmittal Affidavit of Alan R. Silverstein (“Silverstein Aff.”) attaching copies of these documents. See Dkt. 13. 3 Silverstein Aff. Ex. A (“Operating LP Agreement”); Silverstein Aff. Ex. B (“Carry LP

Agreement”). 4 Operating LP Agreement §§ 1.1, 13.1(c); Carry LP Agreement, Sched. A. C.A. No. 2025-0359-KSJM Page 4 of 17 June 30, 2026

to Saffron Hill when the private equity markets improved. When Plaintiff left Saffron

Hill, the parties agreed that he would not receive compensation from Saffron Hill for

his service on any of the portfolio companies’ boards. But Plaintiff would retain his

carried interest in those investments through his limited partnership interest in the

Carry LP.

In October 2011, Luetchens entered into a “Carry Agreement Letter.”5 That

agreement memorialized Luetchens’s right to 37.5% of the capital distributions made

by the Carry LP “to the extent” those distributions “are generated through proceeds

in which a [Saffron Hill entity] made an initial cash investment before Dec 31, 2010.”6

The letter lists 13 companies that fit that description.

The original ten-year term of the Operating LP expired in 2017.7 In June 2019,

the limited partners authorized an extension of the term to December 31, 2022, to

allow for the disposition of its two remaining investments, Agilyx and Coyuchi.8

Meanwhile, in 2018, Luetchens took over as chief executive officer of a Saffron

Hill portfolio company, Optasia Medical. He received sporadic, below-market

compensation in that role. He retained his right to carried interests memorialized in

the Carry Agreement Letter.

5 Silverstein Aff. Ex. D (Carry Agreement Letter).

6 Id.

7 Operating LP Agreement § 2.5.

8 Silverstein Aff. Ex. E. C.A. No. 2025-0359-KSJM Page 5 of 17 June 30, 2026

In late 2022, Landau acquired control of Saffron Hill from outside investors

and reorganized again. As part of that process, Luetchens resigned from all

remaining boards.

According to the Amended Complaint, Landau and Bhatia informed Luetchens

in May 2023 that they were canceling his carried interest. They gave no explanation.

When Luetchens pressed for one, Landau and Bhatia denied that he held any

enforceable right to those interests. The defendants then changed course. They

stopped claiming that they had canceled Luetchens’s carry outright. Instead, they

pursued a transaction that preserved his rights while shifting most of the future

value tied to those rights into the New Operating LP.

Effective March 31, 2025, the Operating LP’s General Partner9 executed a Plan

of Winding Up and Cancellation of Saffron Hill 2 Limited Partnership (the “Wind-Up

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Lear Corp. Shareholder Litigation
967 A.2d 640 (Court of Chancery of Delaware, 2008)
Clinton v. Enterprise Rent-A-Car Co.
977 A.2d 892 (Supreme Court of Delaware, 2009)
Wood v. Coastal States Gas Corp.
401 A.2d 932 (Supreme Court of Delaware, 1979)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Price v. E.I. DuPont De Nemours & Co.
26 A.3d 162 (Supreme Court of Delaware, 2011)
VLIW TECHNOLOGY, LLC v. Hewlett-Packard Co.
840 A.2d 606 (Supreme Court of Delaware, 2003)
Lord v. Souder
748 A.2d 393 (Supreme Court of Delaware, 2000)
Ramsey v. Georgia Southern University Advanced Development Ctr
189 A.3d 1255 (Supreme Court of Delaware, 2018)
SIGA Technologies, Inc. v. PharmAthene, Inc.
67 A.3d 330 (Supreme Court of Delaware, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Shawn Luetchens v. David Landau, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shawn-luetchens-v-david-landau-delch-2026.